SULSWIT-375 is a combination antibiotic formulation containing Sultamicillin 375 mg (a double ester of Ampicillin and Sulbactam). It delivers broad-spectrum antibacterial activity against both Gram-positive and Gram-negative bacteria. Sulbactam acts as a β-lactamase inhibitor, enhancing the efficacy of Ampicillin by preventing bacterial resistance mechanisms. This makes SULSWIT-375 a superior choice for treating complicated infections resistant to conventional penicillins.
This tablet is highly effective in respiratory tract infections, urinary tract infections, skin and soft tissue infections, and ENT conditions like sinusitis, otitis media, and tonsillitis. Its oral administration improves patient compliance, and its high bioavailability ensures faster and better therapeutic outcomes.
Aingo Pharma ensures precision manufacturing under strict GMP standards, offering high-quality and dependable infection management.
Uses:
-
Bacterial Respiratory Tract Infections: Acute bronchitis, chronic bronchitis exacerbations, and community-acquired pneumonia.
-
Urinary Tract Infections (UTIs): Uncomplicated cystitis and complicated pyelonephritis.
-
Skin and Soft Tissue Infections: Cellulitis, furuncles, abscesses, and infected traumatic wounds.
-
ENT Infections: Severe tonsillitis, pharyngitis, acute otitis media, and sinusitis.
Benefits:
-
Broad-Spectrum Coverage: Eradicates a wide array of both Gram-positive and Gram-negative aerobic and anaerobic bacteria.
-
Overcomes Bacterial Resistance: Built-in resistance to beta-lactamases ensures high clinical success rates.
-
Optimized Pharmacokinetics: Excellent gastrointestinal absorption with stable, predictable drug release.
-
Convenient Oral Dosage: Eliminates the immediate need for painful injectable therapies in mild-to-moderate infections, promoting faster recovery at home.
Indications:
-
Bronchitis, pneumonia
-
Pyelonephritis, cystitis
-
Cellulitis, infected wounds
-
Tonsillitis, pharyngitis
Side Effects:
-
Nausea, vomiting
-
Diarrhea
-
Allergic reactions
-
Rash or skin irritation
Sultamicillin Manufacturing Excellence in India
India has established itself as the global hub for advanced antibiotic synthesis, particularly for sophisticated $\beta$-lactamase inhibitor complexes. Producing Sultamicillin Tosylate Dihydrate requires world-class manufacturing infrastructure due to the molecule’s intense sensitivity to environmental moisture and the strict regulatory mandate for allergen isolation.
State-of-the-Art Production Standards
Aingo Pharma ensures precision manufacturing of SULSWIT-375 under strict WHO-GMP and ISO 9001:2015 certified facilities. Because Ampicillin contains a beta-lactam ring, our production takes place in entirely dedicated, isolated manufacturing blocks completely separated from non-penicillin formulations. This rigid segregation completely eliminates the risk of airborne cross-contamination, ensuring absolute product purity and safety for patient distribution.
Advanced B2B Packaging & Stability
To protect the formulation from tropical humidity and degradation, SULSWIT-375 is packed using premium Alu-Alu blister strips. This medical-grade, tamper-proof packaging format acts as a complete barrier against light, oxygen, and moisture, maintaining 100% therapeutic potency throughout its designated shelf life.
